*CDC updating T lab tech with emphasis on testing women (Abbott funds) *ASRM does May issue of Menopausal Medicine on promoting prescribing T for women with low T symptoms (directed to OB/GYN's) (Pfizer funds) *Biosante mysteriously quiet *Compounding pharmacies busier than ever w/T scripts indicating that doctors are already on board with a substance they would prefer to be FDA approved.
26 employees laid-off (great post by the way!) indicates safety data will soon be available. Could indicate other things too: good or bad.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.